1426838-38-1

Basic information

• Product Name: C₂₇H₃₀ClN₃O₂Si
• Synonyms: C₂₇H₃₀ClN₃O₂Si
• CAS NO: 1426838-38-1
• Molecular Weight: 492.093
• Mol File: 1426838-38-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₇H₃₀ClN₃O₂Si(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₇H₃₀ClN₃O₂Si(1426838-38-1)
• EPA Substance Registry System: C₂₇H₃₀ClN₃O₂Si(1426838-38-1)

Safety Data

• Hazardous Substances Data: 1426838-38-1(Hazardous Substances Data)

Upstream product

• 1334313-74-4 (R)-3,3-dimethyl-[1,3]azasilolidine-1,5-dicarboxylic acid 5-[2-(4-bromo-phenyl)-2-oxo-ethyl]ester 1-tert-butyl ester 
• 268224-29-9 (R)-3,3-dimethyl-[1,3]azasilolidine-1,5-dicarboxylic acid 1-tert-butyl ester 
• 268224-19-7 (2R,5R)-2-(((iodomethyl)dimethylsilyl)methyl)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 
• 268224-27-7 (R)-1-tert-butyl-5-methyl 3,3-dimethyl-1,3-azasilolidine-1,5-dicarboxylate 
• 873-73-4 4-n-chlorophenylacetylene 
• 1334313-75-5 (R)-tert-butyl 5-(5-(4-bromophenyl)-1H-imidazol-2-yl)-3,3-dimethyl-1,3-azasilolidine-1-carboxylate 

Relevant articles and documents

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, E, F and L are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.